227 related articles for article (PubMed ID: 7004099)
41. Letter: Birth defects and oral hormone preparations.
David TJ; O'Callaghan SE
Lancet; 1974 Jun; 1(7868):1236. PubMed ID: 4134709
[TBL] [Abstract][Full Text] [Related]
42. Methods for judging human teratogenicity.
Fabro S; Brent RL; Clayson D; Palmer AK; Jebinek LR; Krupp P; Leonov B; Lippman A; Schardein JL; Sever JL
Prog Clin Biol Res; 1985; 163C():177-80. PubMed ID: 3991620
[No Abstract] [Full Text] [Related]
43. Exogenous sex hormone exposure and the risk for major malformations.
Lammer EJ; Cordero JF
JAMA; 1986 Jun; 255(22):3128-32. PubMed ID: 3702023
[TBL] [Abstract][Full Text] [Related]
44. [Allergy to genital hormones and lymphoblastic transformation test].
Sabbah A; Ménard E
Rev Fr Gynecol Obstet; 1969; 64(1):17-20. PubMed ID: 5363396
[No Abstract] [Full Text] [Related]
45. Adverse effects of drugs in the first trimester of pregnancy.
Beeley L
Clin Obstet Gynaecol; 1981 Aug; 8(2):261-74. PubMed ID: 7028345
[No Abstract] [Full Text] [Related]
46. Drugs and pregnancy.
Cohlan SQ
Prog Clin Biol Res; 1980; 44():77-96. PubMed ID: 6771772
[No Abstract] [Full Text] [Related]
47. Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration.
Kelsey FO
Prog Clin Biol Res; 1985; 163C():155-9. PubMed ID: 3991617
[No Abstract] [Full Text] [Related]
48. Teratogenic drugs and their drug interactions with hormonal contraceptives.
Ahn MR; Li L; Shon J; Bashaw ED; Kim MJ
Clin Pharmacol Ther; 2016 Sep; 100(3):217-9. PubMed ID: 27090193
[TBL] [Abstract][Full Text] [Related]
49. Exogenous sex hormones and birth defects: continuing the dialogue.
Nora JJ; Nora AH; Wexler P
Am J Obstet Gynecol; 1982 Dec; 144(7):860-2. PubMed ID: 7148914
[TBL] [Abstract][Full Text] [Related]
50. [Undesirable effects of sex hormone therapy].
Presse Med (1893); 1970 Nov; 78(48):2135-6. PubMed ID: 5482171
[No Abstract] [Full Text] [Related]
51. Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods.
Browne TR
Epilepsy Res Suppl; 1993; 10():31-44. PubMed ID: 8251105
[No Abstract] [Full Text] [Related]
52. Epidemiologic methods in the search for causes of human birth defects.
Ferencz C; Loffredo C; Wilson PD
Teratology; 2000 Apr; 61(4):243-5. PubMed ID: 10716741
[No Abstract] [Full Text] [Related]
53. The susceptibility of the fetus and child to chemical pollutants. Animal tests to screen for human teratogens.
Sullivan FM
Pediatrics; 1974 May; 53(5):822-3. PubMed ID: 4416518
[No Abstract] [Full Text] [Related]
54. The domestic drug regulatory process: why time is of the essence.
Katz R
Epilepsy Res Suppl; 1993; 10():91-106. PubMed ID: 8251109
[No Abstract] [Full Text] [Related]
55. Antifertility drugs. Symposium discussion.
Garcia CR
Fed Proc; 1970; 29(3):1240-2. PubMed ID: 4910272
[TBL] [Abstract][Full Text] [Related]
56. Effects of drugs in pregnancy and during lactation.
Hawkins DF
Proc Annu Symp Eugen Soc; 1981; 16():135-63. PubMed ID: 7346832
[No Abstract] [Full Text] [Related]
57. [Prenatal exposure to birth control pills: risk of fetal death and congenital malformations].
Jellesen R; Andersen AM
Ugeskr Laeger; 2006 Jun; 168(25):2437-42. PubMed ID: 16824365
[TBL] [Abstract][Full Text] [Related]
58. Birth defects caused by isotretinoin--New Jersey.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1988 Mar; 37(11):171-2, 177. PubMed ID: 3126387
[No Abstract] [Full Text] [Related]
59. Pregnancy and pills. New research finds prescriptions may be safer than you think.
Schultz S
US News World Rep; 1999 Apr; 126(13):64-6. PubMed ID: 10351523
[No Abstract] [Full Text] [Related]
60. Teratogenicity from drugs--an increasing problem.
Shepard TH
Dis Mon; 1974 Jun; ():1-32. PubMed ID: 4494537
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
